During the past decade, University of Arizona Sarver Heart Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Sarver Heart Center" #1 sponsor was "University of Arizona" with 3 trials, followed by "Point Biomedical" with 2 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Sarver Heart Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "Horphag Research" with 1 trials as a collaborator and "Intrexon Corporation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Sarver Heart Center" are "Heart Failure" (5 trials), "Cognitive Impairment" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Kidney Injury" (1 trials) and "Amyloidosis, Immunoglobulin Light-chain" (1 trials). Many other conditions were trialed in "University of Arizona Sarver Heart Center" in a lesser frequency.

Most popular intervention types in "University of Arizona Sarver Heart Center" are "Drug" (10 trials), "Device" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Angiotensin-(1-7)" (2 trials), "ARRY-371797 (PF-07265803)" (1 trials), "Arm 1: treatment with Neovasc Reducer" (1 trials) and "Arm 2 (control): Implantation procedure with no device implanted" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Sarver Heart Center" are 20 trials for "All" genders.

Currently, there are NaN active trials in "University of Arizona Sarver Heart Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 9 completed trials in University of Arizona Sarver Heart Center, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Sarver Heart Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".